![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Success of NRTI-sparing Regimens Containing Raltegravir in Therapy-experienced Patients in a German Cohort
|
|
|
Reported by Jules Levin
ICAAC 2015 Sept 17-21 San Diego, CA
Wiesmann F1, Panstruga P1, Braun P1, Lengen S2, Knickmann M2, Scholten S3, Kothemann W4, Neuwirth A4, Knechten H1 and the North-Rhine Study Group
F. Wiesmann1, P. Panstruga2, P. Braun1, S. Lengen2, M. Knickmann2, S. Scholten3, W-A. Kothemann/Neuwirth3, H. Knechten1, North-Rhine Group; 1PZB Aachen, Aachen, Germany, 2INSTO, Aachen, Germany, 3Private Practice Hohenstaufenring, Cologne, Germany
![ICAAC1.gif](../images/092415/092415-7/ICAAC1.gif)
![ICAAC2.gif](../images/092415/092415-7/ICAAC2.gif)
![ICAAC3.gif](../images/092415/092415-7/ICAAC3.gif)
![ICAAC4.gif](../images/092415/092415-7/ICAAC4.gif)
![ICAAC5.gif](../images/092415/092415-7/ICAAC5.gif)
![ICAAC6.gif](../images/092415/092415-7/ICAAC6.gif)
![ICAAC7.gif](../images/092415/092415-7/ICAAC7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|